Hadassah

Hadassah Stem Cell Pioneer Singled Out for Clinical Success

Thursday, Jul 6 2017

Dial back 20 years. Who was one of the first trailblazers in stem cell research?
Prof. Benjamin Reubinoff, head of the Hadassah Medical Organization’s Center for Human Embryonic Stem Cell Research, was not only a pioneer, but today is a physician/scientist whose innovative research has led to potentially promising treatments for patients suffering from debilitating diseases such as age-related macular degeneration (AMD).

Marking Prof. Reubinoff’s pivotal contribution to stem cell science almost eight years ago, Cell Stem Cell magazine chose to recognize his 2009 article in its tenth anniversary issue. Only one other author received that recognition.

As the magazine’s 10th anniversary editorial brings out, quite a few authors who publish their work in Cell Stem Cell  “dream that the work will eventually wind up in the clinic.” Prof. Reubinoff has witnessed the unfolding of that dream, along with his partner, Eyal Banin, head of Hadassah’s Center for Retinal and Macular Degenerations.

The 2009 article reveals their successful creation of retinal epithelium cells (RPEs) from human embryonic stem cells and the rescue of the retina’s structure and function in an animal model.

Today, Cell Cure, founded by Prof. Reubinoff, is tackling macular degeneration with a stem cell therapy that evolved from that work. Their Phase I/IIa clinical trial, now in progress, has shown that the cells they transplanted into the eyes of patients with AMD have engrafted with no major adverse reactions. And they have remained in place for at least a year.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Feb 14 2018

Student with MS Running the Jerusalem Marathon to Support Hadassah’s MS Program

Thanks to his physicians at the Hadassah Medical Center, Dov Guggenheim, who was diagnosed with Multiple Sclerosis (MS) in 2015, has gone from “depressed to optimistic, paralyzed to athletic, and, most important, hopeless to hopeful.”

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Texas Tropical Disease Expert Meets with Hadassah Infectious Disease Specialists

Dr. Peter Jay Hotez, renowned professor in the Departments of Pediatrics and Molecular Virology and Microbiology at Houston (Texas) Baylor College of Medicine and Dean of its National School of Tropical Medicine, met with two Hadassah Medical Organization infectious disease specialists to discuss regional cooperation in fighting tropical diseases, such as the now-infamous Zika virus and leishmaniosis, which is contracted from sand flies.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Large Hadassah Study Identifies Predictor of Greater Risk of End-Stage Renal Disease

The findings of a nationwide study of over a million and a half Israeli adolescents, conducted by researchers at the Hadassah-Hebrew University Braun School of Public Health and Community Medicine, suggest that kidney disease in childhood is associated with a significantly increased risk of end-stage renal disease (ESRD) in adulthood, even if kidney function seems normal in adolescence.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Israeli Start-up’s Algorithm Predicts Which Diabetic Patients Will Suffer Kidney Dysfunction Within One Year

The Israeli start-up Medial EarlySign has created a machine-learning-based model that has proven to identify diabetic patients who are at the highest risk for experiencing renal dysfunction within one year.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More